Phase II trial of YHI-1003
Phase 2
- Conditions
- advanced or relapsed gynecologic cancer (ovarian, endometric or cervical cancer)
- Registration Number
- JPRN-jRCT2080222238
- Lead Sponsor
- Yakult Honsha Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Female
- Target Recruitment
- 96
Inclusion Criteria
(1)Patients with a histologically-diagnosed ovarian , endometric or cervical cancer
(2)Patients with a history of treatment with platinum-based chemotherary
(3)Patients who have agreed with the investigation of biomarkers
(4)Patients who can be treated with oral medications
(5)Patients with at least one measurable disease
Exclusion Criteria
(1)Patients with a history of treatment with PI3K, AKT or mTOR inhibitor
(2)Patients with uncontrolled intercurrent illness
(3)Patients with brain metastases or suspected brain metastases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method